$457 Million is the total value of Parkman Healthcare Partners LLC's 82 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 39.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $26,366,000 | -38.8% | 1,501,460 | -12.2% | 5.76% | -42.3% |
| DXCM | Buy | DEXCOM INC | $21,546,000 | +59.0% | 50,458 | +33.8% | 4.71% | +49.7% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $19,326,000 | +33.4% | 52,245 | +4.5% | 4.22% | +25.6% |
| ISRG | New | INTUITIVE SURGICAL INC | $18,037,000 | – | 19,613 | +100.0% | 3.94% | – |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $16,923,000 | +35.1% | 94,324 | +26.0% | 3.70% | +27.2% |
| IQV | Buy | IQVIA HLDGS INC | $16,567,000 | +29.9% | 68,369 | +3.5% | 3.62% | +22.3% |
| DHR | Sell | DANAHER CORPORATION | $14,981,000 | +2.4% | 55,824 | -14.1% | 3.28% | -3.5% |
| HUM | Sell | HUMANA INC | $14,469,000 | +4.6% | 32,681 | -1.0% | 3.16% | -1.5% |
| NTRA | Sell | NATERA INC | $13,686,000 | -3.7% | 120,547 | -13.8% | 2.99% | -9.3% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $12,708,000 | +38.4% | 74,967 | +15.3% | 2.78% | +30.4% |
| AVTR | Buy | AVANTOR INC | $12,568,000 | +72.3% | 353,941 | +40.4% | 2.75% | +62.3% |
| CDMO | Sell | AVID BIOSERVICES INC | $12,184,000 | -1.0% | 475,000 | -29.6% | 2.66% | -6.8% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $11,371,000 | +46.6% | 304,686 | +0.5% | 2.49% | +38.1% |
| PODD | Buy | INSULET CORP | $9,701,000 | +19.3% | 35,340 | +13.4% | 2.12% | +12.3% |
| ICAD | Sell | ICAD INC | $9,196,000 | -33.1% | 531,255 | -18.0% | 2.01% | -37.0% |
| ITMR | Buy | ITAMAR MED LTDsponsored ads | $7,960,000 | -1.2% | 338,001 | +0.5% | 1.74% | -7.0% |
| RGEN | New | REPLIGEN CORP | $7,733,000 | – | 38,740 | +100.0% | 1.69% | – |
| XLRN | Sell | ACCELERON PHARMA INC | $7,539,000 | -11.5% | 60,074 | -4.3% | 1.65% | -16.6% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $7,470,000 | +11.5% | 401,207 | +7.2% | 1.63% | +5.0% |
| COO | Buy | COOPER COS INC | $7,366,000 | +155.7% | 18,588 | +147.8% | 1.61% | +140.7% |
| SGEN | New | SEAGEN INC | $7,132,000 | – | 45,176 | +100.0% | 1.56% | – |
| XRAY | Buy | DENTSPLY SIRONA INC | $6,987,000 | +119.0% | 110,455 | +120.9% | 1.53% | +106.1% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $6,773,000 | -23.6% | 246,637 | -21.9% | 1.48% | -28.1% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $6,767,000 | +7.4% | 72,267 | +5.6% | 1.48% | +1.2% |
| STXS | Buy | STEREOTAXIS INC | $6,546,000 | +44.1% | 679,082 | +0.5% | 1.43% | +35.8% |
| GOSS | Buy | GOSSAMER BIO INC | $6,389,000 | +18.5% | 786,870 | +35.0% | 1.40% | +11.7% |
| NVRO | New | NEVRO CORP | $5,934,000 | – | 35,792 | +100.0% | 1.30% | – |
| CTLT | Sell | CATALENT INC | $5,918,000 | -29.3% | 54,739 | -31.2% | 1.29% | -33.4% |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $5,834,000 | – | 130,000 | +100.0% | 1.28% | – |
| APEN | Buy | APOLLO ENDOSURGERY INC | $5,599,000 | +1255.7% | 691,214 | +821.6% | 1.22% | +1175.0% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $5,565,000 | +123.7% | 351,961 | +43.8% | 1.22% | +110.9% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $5,440,000 | +14.4% | 136,380 | +28.9% | 1.19% | +7.7% |
| INFU | Sell | INFUSYSTEM HLDGS INC | $5,230,000 | -7.9% | 251,567 | -9.8% | 1.14% | -13.3% |
| AXGN | Buy | AXOGEN INC | $5,136,000 | +19.8% | 237,652 | +12.3% | 1.12% | +12.9% |
| IMUX | Buy | IMMUNIC INC | $5,077,000 | -20.6% | 414,087 | +3.2% | 1.11% | -25.2% |
| IDXX | Buy | IDEXX LABS INC | $4,842,000 | +29.7% | 7,667 | +0.5% | 1.06% | +22.0% |
| CDXS | Buy | CODEXIS INC | $4,669,000 | +104.0% | 206,067 | +106.1% | 1.02% | +92.3% |
| SPNE | Buy | SEASPINE HLDGS CORP | $4,615,000 | +39.0% | 225,000 | +18.0% | 1.01% | +31.0% |
| MNKD | Buy | MANNKIND CORP | $4,388,000 | +179.8% | 805,047 | +101.3% | 0.96% | +163.5% |
| MRVI | Sell | MARAVAI LIFESCIENCES HLDGS I | $3,756,000 | -6.3% | 90,000 | -20.0% | 0.82% | -11.8% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $3,545,000 | -23.7% | 36,393 | -8.4% | 0.78% | -28.1% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $3,534,000 | -12.0% | 57,978 | -11.0% | 0.77% | -17.1% |
| OM | Buy | OUTSET MED INC | $3,515,000 | -0.6% | 70,336 | +8.2% | 0.77% | -6.3% |
| KOD | Buy | KODIAK SCIENCES INC | $3,413,000 | -8.9% | 36,702 | +11.1% | 0.75% | -14.3% |
| HBIO | New | HARVARD BIOSCIENCE INC | $3,352,000 | – | 402,367 | +100.0% | 0.73% | – |
| SUPN | New | SUPERNUS PHARMACEUTICALS INC | $3,092,000 | – | 100,415 | +100.0% | 0.68% | – |
| NOTV | Buy | INOTIV INC | $3,068,000 | +104.5% | 115,000 | +53.3% | 0.67% | +92.8% |
| STRO | Sell | SUTRO BIOPHARMA INC | $3,037,000 | -34.2% | 163,389 | -19.4% | 0.66% | -38.0% |
| HCAT | Sell | HEALTH CATALYST INC | $2,804,000 | -8.2% | 50,515 | -22.6% | 0.61% | -13.5% |
| ETNB | Buy | 89BIO INC | $2,540,000 | +5.0% | 135,848 | +33.0% | 0.56% | -1.1% |
| EDAP | Sell | EDAP TMS S Asponsored adr | $2,460,000 | -48.9% | 346,926 | -39.5% | 0.54% | -51.9% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $2,454,000 | +8.9% | 80,839 | +7.1% | 0.54% | +2.5% |
| SIEN | New | SIENTRA INC | $2,402,000 | – | 301,746 | +100.0% | 0.52% | – |
| SDGR | Sell | SCHRODINGER INC | $2,314,000 | -25.0% | 30,608 | -24.3% | 0.51% | -29.3% |
| BLRX | Buy | BIOLINERX LTDsponsored ads | $2,063,000 | +71.9% | 734,032 | +70.7% | 0.45% | +61.6% |
| Buy | TRILLIUM THERAPEUTICS INC | $2,050,000 | +27.0% | 211,385 | +40.6% | 0.45% | +19.5% | |
| ONCT | Sell | ONCTERNAL THERAPEUTICS INC | $1,973,000 | -69.5% | 415,384 | -46.7% | 0.43% | -71.3% |
| ALT | New | ALTIMMUNE INC | $1,970,000 | – | 200,000 | +100.0% | 0.43% | – |
| KDMN | Sell | KADMON HLDGS INC | $1,942,000 | -39.4% | 501,740 | -39.1% | 0.42% | -42.9% |
| ANIP | New | ANI PHARMACEUTICALS INC | $1,940,000 | – | 55,346 | +100.0% | 0.42% | – |
| PFMT | Sell | PERFORMANT FINL CORP | $1,865,000 | +15.6% | 497,334 | -33.7% | 0.41% | +9.1% |
| CSLT | Buy | CASTLIGHT HEALTH INCcl b | $1,782,000 | +135.7% | 677,734 | +35.4% | 0.39% | +122.9% |
| REPH | Buy | RECRO PHARMA INC | $1,781,000 | +6.1% | 770,833 | +28.1% | 0.39% | -0.3% |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $1,704,000 | -13.7% | 393,449 | +0.5% | 0.37% | -18.6% |
| SURF | Sell | SURFACE ONCOLOGY INC | $1,703,000 | -13.5% | 228,267 | -9.5% | 0.37% | -18.6% |
| TELA | New | TELA BIO INC | $1,611,000 | – | 100,000 | +100.0% | 0.35% | – |
| FULC | Buy | FULCRUM THERAPEUTICS INC | $1,534,000 | +3.6% | 146,389 | +16.4% | 0.34% | -2.6% |
| NTLA | New | INTELLIA THERAPEUTICS INC | $1,214,000 | – | 7,500 | +100.0% | 0.26% | – |
| TLMD | Buy | SOC TELEMED INC | $1,184,000 | -2.0% | 208,121 | +8.3% | 0.26% | -7.5% |
| MTEM | Sell | MOLECULAR TEMPLATES INC | $1,108,000 | -47.1% | 141,663 | -14.6% | 0.24% | -50.2% |
| VCEL | Sell | VERICEL CORP | $1,068,000 | -82.5% | 20,340 | -81.5% | 0.23% | -83.6% |
| FBRX | Buy | FORTE BIOSCIENCES INC | $1,056,000 | -1.4% | 31,402 | +0.5% | 0.23% | -7.2% |
| VERA | New | VERA THERAPEUTICS INCcl a | $1,003,000 | – | 75,638 | +100.0% | 0.22% | – |
| KRMD | Sell | REPRO MED SYS INC | $932,000 | +1.2% | 201,256 | -23.1% | 0.20% | -4.7% |
| BCEL | Sell | ATRECA INC | $857,000 | -63.2% | 100,628 | -33.8% | 0.19% | -65.4% |
| ASLN | Sell | ASLAN PHARMACEUTICALS LTDads | $745,000 | -31.6% | 225,881 | -30.5% | 0.16% | -35.6% |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $648,000 | +0.6% | 49,969 | +0.8% | 0.14% | -4.7% |
| ARPO | Sell | AERPIO PHARMACEUTICALS INC | $598,000 | -53.7% | 353,957 | -64.6% | 0.13% | -56.3% |
| VSTM | New | VERASTEM INC | $512,000 | – | 125,797 | +100.0% | 0.11% | – |
| AMAM | New | AMBRX BIOPHARMA INCsponsored ads | $294,000 | – | 15,000 | +100.0% | 0.06% | – |
| EYEG | Buy | EYEGATE PHARMACEUTICALS INC | $275,000 | -26.7% | 75,647 | +0.5% | 0.06% | -31.0% |
| CALA | New | CALITHERA BIOSCIENCES INC | $210,000 | – | 100,628 | +100.0% | 0.05% | – |
| BFLY | Exit | BUTTERFLY NETWORK INC | $0 | – | -30,315 | -100.0% | -0.12% | – |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -40,364 | -100.0% | -0.21% | – |
| KALA | Exit | KALA PHARMACEUTICALS INC | $0 | – | -148,433 | -100.0% | -0.23% | – |
| SILK | Exit | SILK RD MED INC | $0 | – | -20,000 | -100.0% | -0.24% | – |
| PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -30,207 | -100.0% | -0.26% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -13,962 | -100.0% | -0.31% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -80,603 | -100.0% | -0.35% | – |
| ATEC | Exit | ALPHATEC HLDGS INC | $0 | – | -100,000 | -100.0% | -0.37% | – |
| PROF | Exit | PROFOUND MED CORP | $0 | – | -84,399 | -100.0% | -0.40% | – |
| ONEM | Exit | 1LIFE HEALTHCARE INC | $0 | – | -45,217 | -100.0% | -0.41% | – |
| HAE | Exit | HAEMONETICS CORP MASS | $0 | – | -17,500 | -100.0% | -0.45% | – |
| CRIS | Exit | CURIS INC | $0 | – | -195,991 | -100.0% | -0.52% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -15,000 | -100.0% | -0.57% | – |
| NUAN | Exit | NUANCE COMMUNICATIONS INC | $0 | – | -91,173 | -100.0% | -0.92% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -70,089 | -100.0% | -1.08% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -45,059 | -100.0% | -2.60% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -50,000 | -100.0% | -3.70% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.